Agreement signedAgreed 8 Oct 2023
Bristol-Myers Squibb Company /
Mirati Therapeutics, Inc.
Bristol-Myers Squibb Company agrees to buy Mirati Therapeutics, Inc.
01 / BuyerBristol-Myers Squibb Company
02 / TargetMirati Therapeutics, Inc.
Source-verifiedWhat happened
Bristol-Myers Squibb Company agreed to acquire Mirati Therapeutics, Inc. for approximately $4.8 billion in equity value, according to a filing dated Jan. 23, 2024.
The source
Everything on this page comes from the source below.
01
Source · Original source
Bristol-Myers Squibb Company agrees to buy Mirati Therapeutics, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verifiedAnnounced
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly